Clinical Trial Update: Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a conditioning regimen of busulfan, melphalan, and thiotepa for patients undergoing autologous stem cell transplantation in Hodgkin and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)
• Melphalan (Melphalan)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-05-11